Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity.
about
Predicting full thickness skin sensitization using a support vector machineVascular endothelial growth factor as an anti-angiogenic target for cancer therapyPreclinical molecular imaging of tumor angiogenesis.Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity.Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2.Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.PET imaging of early response to the tyrosine kinase inhibitor ZD4190.Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.PET Imaging of Angiogenesis.Angiogenesis drives psoriasis pathogenesis.Extracellular matrix in angiogenesis: dynamic structures with translational potential.Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationAnti-angiogenesis target therapy for advanced osteosarcoma (Review).Topical treatment of contact dermatitis by pine processionary caterpillar.Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene.Functional heterogeneity of the bone marrow vascular nicheImpaired contact hypersensitivity reaction and reduced production of vascular endothelial growth factor in tumor necrosis factor-alpha gene-deficient mice.Electrophilic nitro-fatty acids suppress allergic contact dermatitis in mice.
P2860
Q28396621-BDC86CAE-641B-4C05-8290-9B3730E1EFCEQ30455612-B2817380-B9AB-487D-B32E-551DC24BF3DFQ30475818-D833E2EB-9755-4221-AE58-C5024B5AE868Q33288440-5D09D72A-D791-4251-84F8-6053B1CE1116Q33304299-9ED08B1A-E1F2-4279-AB90-C11FF832FA9EQ33764990-C20CB3BE-EC11-4A05-A464-39744FE3552CQ35249646-B1E3B42E-F8C9-48A6-8649-CFF72640CED2Q36392576-CB5C831F-4122-41D7-BC40-94C41EAE4022Q37366243-24A03616-CACA-4517-8AC0-8316B064442DQ37534974-849C4D64-3A91-4EBC-81F6-ABAB18D42BE4Q37892625-BCF401EE-47A3-47CD-BE10-E3F3B1A790B8Q38008362-610AAAAF-43A6-4F92-8FE7-FAF20B683B9AQ39401628-3F58C42A-F338-40AA-A8FD-1BAAE9A7DFB7Q41880890-E0DDF75E-773F-4BA1-B914-60CFCDAE914BQ42087723-439ADBC7-5431-40FC-AE2E-FD3B3ACE2A44Q42419004-14BE80C6-00D1-4434-8BDD-45EA0FFAB40EQ46841106-AB1285F3-97D6-4646-AF1B-F502478B37FDQ48314088-AC14159E-F35A-4A1D-8A69-4FAA0489571B
P2860
Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Anti-vascular endothelial grow ...... sses contact hypersensitivity.
@en
Anti-vascular endothelial growth factor receptor-2
@nl
type
label
Anti-vascular endothelial grow ...... sses contact hypersensitivity.
@en
Anti-vascular endothelial growth factor receptor-2
@nl
prefLabel
Anti-vascular endothelial grow ...... sses contact hypersensitivity.
@en
Anti-vascular endothelial growth factor receptor-2
@nl
P2093
P2860
P1476
Anti-vascular endothelial grow ...... sses contact hypersensitivity.
@en
P2093
Adam J Mamelak
Binghe Wang
Brandon G Howell
Clemens Esche
Daniel J Hicklin
Daniel N Sauder
Go Nagasaki
Hideaki Watanabe
Irwin Freed
Masashi Nakayama
P2860
P304
P356
10.1111/J.0906-6705.2004.00240.X
P577
2004-11-01T00:00:00Z